— Know what they know.
Not Investment Advice

TWST Short Interest

Twist Bioscience Corporation
1W: +12.0% 1M: -11.0% 3M: +87.0% YTD: +393.5% 1Y: +368.6% 3Y: +854.3% 5Y: +33.4%
$159.85
+14.60 (+10.05%)
Pre-Market: $162.13 (+2.28, +1.43%)
Weekly Expected Move ±14.1%
$100 $120 $140 $160 $179
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 34 · $10.5B mcap · 62M float · 3.42% daily turnover · Short 54% of daily vol
Credit Risk of going bust: lower than 76% of companies Debt: 0.9% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.04 (down more than 99.9%), Twist Bioscience Corporation would be worth roughly what it owes.
Total debt $93.6M against a stock market value of $10.52B.
Distance to default 8.83 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $8.6M (short-term plus half of long-term), stock volatility 77.6%; Altman Z'' -4.23. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-27
62.6%
Short Ratio
of total volume
47.8%
20-Day Avg
44.8%
50-Day Avg
▲ Rising
5-Day Trend
0.5M
Short Volume
0.8M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-27
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 439,928 703,950 62.5%
NYSE 29,673 46,840 63.4%
BATS 9,297 14,104 65.9%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms